Statements (50)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:acquisition |
Synthetic Genomics, Inc. acquired by a private equity firm
|
| gptkbp:awards |
biotechnology innovation awards
|
| gptkbp:ceo |
gptkb:J._Craig_Venter
|
| gptkbp:collaboration |
gptkb:Harvard_University
gptkb:Stanford_University gptkb:University_of_California,_San_Diego Synthetic Genomics, Inc. collaborates with pharmaceutical companies |
| gptkbp:focus |
gptkb:biotechnology
|
| gptkbp:founded |
gptkb:2005
|
| gptkbp:founder |
gptkb:J._Craig_Venter
|
| gptkbp:goal |
sustainable energy solutions
environmental remediation improve human health develop synthetic organisms |
| gptkbp:headquarters |
gptkb:La_Jolla,_California
|
| https://www.w3.org/2000/01/rdf-schema#label |
Synthetic Genomics, Inc.
|
| gptkbp:impact |
development of new therapies
influence on biotechnology industry advancements in synthetic biology contributions to genomics creation of bio-based products |
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:invention |
synthetic biology patents
|
| gptkbp:investment |
gptkb:venture_capital
|
| gptkbp:notable_project |
synthetic bacterial genome
|
| gptkbp:number_of_employees |
50-100
|
| gptkbp:partnership |
gptkb:NASA
gptkb:United_States_Department_of_Energy |
| gptkbp:research_areas |
gptkb:pharmaceuticals
agriculture biofuels vaccines |
| gptkbp:research_focus |
metabolic engineering
cellular systems genetic circuits genome design |
| gptkbp:research_partnership |
government agencies
non-profit organizations international research institutions |
| gptkbp:technology |
gptkb:CRISPR_technology
DNA sequencing genetic engineering gene editing biomanufacturing protein engineering genome synthesis |
| gptkbp:website |
www.syntheticgenomics.com
|
| gptkbp:bfsParent |
gptkb:Venter_Institute_for_Synthetic_Biology
|
| gptkbp:bfsLayer |
8
|